Are There Clinically Significant Differences Among the First and Second Generation EGFR TKIs (Iressa, Tarceva, Gilotrif)?

Spreaker is getting a new look!

Preview our new listening experience personalized just for you.

Are There Clinically Significant Differences Among the First and Second Generation EGFR TKIs (Iressa, Tarceva, Gilotrif)?

GRACEcast

00:00

03:24

Like Download

Drs. Ben Solomon, Leora Horn, & Jack West review whether the data and clinical experience suggest any clinically significant differences among the first and second generation EGFR TKIs (Iressa, Tarceva, Gilotrif/Giotrif).

8 years ago #2015, #acquired, #azd9291, #ben, #cancergrace, #co1686, #egfr, #grace, #gracecast, #horn, #jack, #leora, #mutation, #resistance, #sequence, #solomon, #t790m, #tki, #treatment, #west

0 Comments

This episode has no messages yet. Be the first to write a message!

Spreaker is getting a new look!

Are There Clinically Significant Differences Among the First and Second Generation EGFR TKIs (Iressa, Tarceva, Gilotrif)?

Are There Clinically Significant Differences Among the First and Second Generation EGFR TKIs (Iressa, Tarceva, Gilotrif)?

0 Comments

For Creators

For Listeners & Advertisers

Choose Language

Follow us